Picture of Macrogen logo

038290 Macrogen Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual income statement for Macrogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue112,603129,175138,617132,803135,777
Cost of Revenue
Gross Profit42,19052,15853,59349,24047,129
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses101,506126,758141,440144,482147,908
Operating Profit11,0982,417-2,822-11,678-12,131
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5,55014,904-29,104-20,233-9,897
Provision for Income Taxes
Net Income After Taxes3,8052,312-22,005-16,751-7,784
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income88,3371,112-22,253-16,814-7,603
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income88,4751,112-22,253-16,814-7,603
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS97.3736-1,705-861-370
Dividends per Share